Sign in
4

Changes in Ownership

SUTRO BIOPHARMA, INC. Filed Acc 0001415889-25-010384

Options or other derivatives

  • CHIEF SCIENTIFIC OFFICER acquired 236,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER 2025-04-04 Grant or award · Stock Option (Right to Buy) +122,500 122,500 D
Gerber Hans-Peter CHIEF SCIENTIFIC OFFICER 2025-04-04 Grant or award · Restricted Stock Units (RSUs) +113,750 113,750 D
Loading xslF345X05/form4-04082025_080457.xml…